Human Recombinant Granulocyte colony-stimulating factor is a hematopoietic growth factor; most commonly known to be used for chemotherapy-induced neutropenia for the mobilization of peripheral blood stem cells. A case of 43 years old lady, post radical mastectomy for breast cancer and one cycle of chemotherapy was encountered with the development of massive psoriasis-like eruptions all over the body including the scalp with adherent silvery scales after 10 days of administration of granulocyte colony-stimulating factor with the failure of remission even after months of treatment. Specific psoriasis signs were seen positive but the Biopsy and Reflectance Confocal Microscopy was inconclusive for the diagnosis of Psoriasis, therefore managed as an allergic drug eruption with immediate cessation of G-CSF administration. The rash improved significantly with no new appearances. However during follow up, the island of patches persisted on certain areas, which made it a not so clear case of a drug eruption because of its incomplete remission even after cessation of the drug. So we would like to present a case of G-CSF induced drug eruption coinciding with Psoriasis features suggestive of early presentation of Psoriasis. The main objective of this report is to analyze whether the eruptions caused by G-CSF is a drug eruption or an initiation towards the overall progression of Psoriasis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.